News
Ariosa Diagnostics Expands Harmony Prenatal Test to Twin Pregnancies and Launches New X,Y Analysis Test
May 20, 2013
American College of Medical Genetics Supports Non-invasive Prenatal Screening for Fetal Aneuploidy Detection in Pregnant Women
April 6, 2013
New Studies Highlight Obstetrician Experiences and Attitudes Toward Adoption of Non-Invasive Prenatal Testing in the Practice Setting
April 2, 2013
Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
March 18, 2013
Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher
February 25, 2013
New Study Demonstrates Non-Invasive Prenatal Testing in High-Risk Women at Price Point of $795 is Clinically Beneficial and Cost-Saving to the Healthcare System
January 29, 2013
Ariosa Diagnostics Enters 2013 with New Offering and Global Expansion
January 9, 2013
Ariosa Diagnostics Announces Partnership with The Doctors Laboratory (TDL) to Distribute the Harmony™ Prenatal Test in the UK
January 9, 2013
WellPoint Supports Cell-Free Fetal DNA-Based Prenatal Screening for Fetal Aneuploidy in Certain Pregnancies
December 20, 2012
Ariosa Diagnostics to Present at the JP Morgan 31st Annual Healthcare Conference
December 19, 2012
Clinical Utility of the Harmony™ Prenatal Test in General Screening Population Highlighted During Fetal Medicine Foundation Course
December 3, 2012
Ariosa Diagnostics Responds to the ACOG Committee Opinion on "Noninvasive Prenatal Testing for Fetal Aneuploidy"
November 21, 2012
Ariosa Diagnostics to Present Clinical Data on the Harmony™ Prenatal Test at American Society of Human Genetics Annual Meeting
November 5, 2012
The Fetal Medicine Centre and Ariosa Diagnostics™ Partner to Bring the Harmony™ Prenatal Test to the United Kingdom
October 18, 2012
Clinical Study Highlights Detection of Fetal Trisomy 13 with the Harmony™ Prenatal Test
September 24, 2012
Clinical Utility of Harmony™ Prenatal Test, a Non-Invasive Prenatal Test, in General Screening Population Demonstrated in New Study
September 5, 2012
New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
August 27, 2012
Ariosa Diagnostics Completes Clinical Study of Harmony™ Prenatal Test on a General Pregnant Patient Population
July 24, 2012
Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics
July 6, 2012
First Large Cohort Validation Study on Non-invasive Prenatal Testing for Fetal Trisomy Detection Completed Using the Harmony™ Prenatal Test
June 4, 2012
Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
May 29, 2012
Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
May 23, 2012
Ariosa Diagnostics Announces Nationwide Launch of the Harmony™ Prenatal Test Through LabCorp
May 7, 2012
Ariosa Diagnostics Strengthens Management Team with Appointment of Thomas J. Musci, M.D. as Vice President, Clinical Development and Medical Affairs
May 1, 2012
Ariosa Diagnostics Announces Completion of Laboratory-Developed Test Study for the Harmony™ Prenatal Test
Mar. 26, 2012
New Data Publication in the American Journal of Obstetrics & Gynecology Highlights Proprietary Algorithm for Ariosa's Non-Invasive Prenatal Assay
Jan. 27, 2012
Ariosa Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Ariosa's Technology
Jan. 26, 2012
Ariosa Diagnostics Announces Launch of U.S. Clinical Study Comparing New Non-Invasive Prenatal Test to Current First-Trimester Standard in 25,000 Women
Jan. 12, 2012
Ariosa Diagnostics Announces Publication of First Peer-Reviewed Data for New Non-Invasive Prenatal Test
Jan. 9, 2012
Ariosa Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing
Jan. 9, 2012
Ariosa Diagnostics Emerges From Stealth With New Blood-Based Prenatal Test
Jan. 6, 2012
- Media Contact
- Jen Bruursema
- Ariosa Diagnostics
- Mobile Ph/Txt: 202-316-4553
- jbruursema@ariosadx.com